Eurofins Viracor Launches Assays for Pneumococcal Antibody Detection, Expanding Serotype Coverage to Support Immunocompromised Patient Care
Eurofins Viracor has launched multiplex pneumococcal antibody assays covering all vaccine serotypes, including PCV21. The 32‑serotype panel improves accuracy and supports personalized immunity monitoring. This advancement reinforces the company’s leadership in immunology diagnostics.
Tandem Meetings 2026 - Transplantation & Cellular Therapy Meetings
Eurofins Viracor will be exhibiting at the Tandem Meetings 2026 - Transplantation & Cellular Therapy of ASTCT & CIBMTR, February 4 - 7, Booth #511 at the Salt Palace Convention Center, Salt Lake City, Utah.
All posts
Categories
Chat With An Expert